Also indexed as: Beta hydroxy-beta-methylbutyrate
What does it do? HMB (beta hydroxy-beta-methylbutyrate) is a
metabolite of the essential amino acid leucine (one of
the branched-chain amino acids). As with other
amino acid-related substances, HMB appears to play a role in the synthesis of
protein—including the protein that builds new muscle tissue.
Animal research suggests that HMB may improve the growth of lean muscle tissue,1
but only preliminary and limited research in humans supports the potential link between HMB
and enhanced muscle building2 or endurance performance3 in athletes. One study involving people involved in a
regular weight-lifting program found that supplements of 3 grams per day of HMB, compared with
no supplements, contributed to greater gains of muscle mass and strength over the seven-week
study.4 However, a double-blind, controlled trial found no effect of 3 grams per
day of HMB for four weeks on body composition or exercise performance in 41 weight-training
football players.5 6
Where is it found? Small amounts of HMB are present in many
foods of animal and plant origin, especially alfalfa and
catfish. The amino acid leucine is metabolized into a
compound called alpha-ketoisocaproate (KIC), which is then turned into HMB by the body.
Dietary supplements of HMB are also available.
HMB has been used in
connection with the following conditions (refer to the individual
health concern for complete information):
Who is likely to be deficient? HMB is not an essential
nutrient. The body creates HMB from leucine, so any diet containing sufficient amounts of
leucine (most do) should lead to the adequate production of HMB. Limited evidence indicates
that athletes may benefit from supplemental intake of HMB.
How much is usually taken? Most people do not need to use HMB.
For those involved in regular exercise who do choose to take this supplement, the research
generally uses 3 grams of HMB per day in combination with resistive exercise, such as weight
lifting.
Are there any side effects or interactions? No safety issues
have been reported in the limited number of studies currently available.
At the time of writing, there were no well-known drug interactions
with HMB.
References:
1. Nissen SL, Morrical D, Fuller JC. Effects of the leucine catabolite
beta-hydroxy-beta-methylbutyrate (HMB) on the growth and health of growing lambs. J Animal
Sci 1994;77:243.
2. Nissen S, Panton L, Wilhelm R, et al. Effect of
beta-hydroxy-beta-methylbutyrate (HMB) supplementation on strength and body composition of
trained and untrained males undergoing intense resistance training. FASEB J
1996;10:A287 [abstract].
3. Vukovich MD, Adams GD. Effect of beta-hydroxy beta-methylbutyrate
(HMB) VO2 peak and maximal lactate in endurance trained cyclists. Med Sci Sports
Exerc 1997;29:S252 [abstract]
4. Nissen S, Sharp R, Ray M, et al. Effect of leucine metabolite
beta-hydroxy-beta-methylbutyrate on muscle metabolism during resistive-exercise training.
J Appl Physiol 1996;81:2095–104.
5. Kreider R, Ferreira M, Wilson M, et al. Effects of calcium beta-HMB
supplementation with or without creatine during training on body composition alterations.
FASEB J 1997;11:A374 [abstract].
6. Almada A, Kreider R, Ferreira M, et al. Effects of calcium beta-HMB
supplementation with or without creatine during training on strength & sprint capacity.
FASEB J 1997;11:A374 [abstract].
Copyright © 2002 Healthnotes, Inc. All rights reserved.
www.healthnotes.com
Learn more about Healthnotes, the company.
Learn more about the authors of Healthnotes.
The information presented in Healthnotes is for informational
purposes only. It is based on scientific studies (human, animal, or in vitro),
clinical experience, or traditional usage as cited in each article. The results reported may
not necessarily occur in all individuals. For many of the conditions discussed, treatment with
prescription or over-the-counter medication is also available. Consult your doctor,
practitioner, and/or pharmacist for any health problem and before using any supplements or
before making any changes in prescribed medications. Information expires December 2003.
|